MF
TEVA icon

Magnetar Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Magnetar Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,305,772
Closed -$9.82K – 1510
2022
Q2 		$9.82K Buy
1,305,772
+786,858
+152% +$6.86M 0.1% 188
2022
Q1 		$4.87M Buy
518,914
+15,471
+3% +$129K 0.05% 363
2021
Q4 		$4.03M Buy
+503,443
New +$4.54M 0.04% 453
2019
Q4 		– Sell
-449,778
Closed -$3.09M – 644
2019
Q3 		$3.09M Sell
449,778
-57,122
-11% -$438K 0.08% 130
2019
Q2 		$4.68M Buy
506,900
+218,900
+76% +$2.64M 0.09% 95
2019
Q1 		$4.52M Sell
288,000
-287,001
-50% -$5.06M 0.12% 80
2018
Q4 		$8.87M Buy
575,001
+255,000
+80% +$5.23M 0.22% 57
2018
Q3 		$6.89M Buy
+320,001
New +$7.43M 0.12% 74

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Magnetar Financial's TEVA Position: Q3 2022 in Review

Magnetar Financial sold out of Teva Pharmaceuticals (TEVA) in Q3 2022, closing a stake of 1,305,772 shares — an estimated $9.82K sold.

Magnetar Financial first reported a position in TEVA in Q3 2018 and held it in 8 quarters. The position peaked at $8.87M in Q4 2018. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Magnetar Financial reported no remaining Teva Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Magnetar Financial sold 1,305,772 Teva Pharmaceuticals shares in Q3 2022, an estimated $9.82K.
  • Magnetar Financial first reported a position in Teva Pharmaceuticals in Q3 2018 and held it in 8 quarters.
  • Magnetar Financial's Teva Pharmaceuticals position peaked at $8.87M in Q4 2018.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Magnetar Financial's 13F filing for Q3 2022, filed 14 Nov 2022.